阿尔茨海默病神经病理亚型中Meynert基底核的选择性易损性
这项横断面研究基于FLAME队列中1361例阿尔茨海默病(AD)亚型和103例非痴呆对照,定量评估Meynert基底核(nbM)的神经原纤维缠结(NFT)和神经元密度。结果发现海马保留型AD的nbM中NFT计数最高、神经元密度最低,提示年轻时发病的AD尤其是海马保留型存在更严重的胆碱能缺陷。
要点
- 海马保留型AD的nbM中NFT中位数最高(14/0.125mm²),神经元密度最低(22/mm²)。
- 典型AD中nbM的NFT积累与女性、APOE ε4及较低MMSE评分相关。
- 边缘 predominance 型AD的nbM NFT积累与人口学及临床进展变量无关。
核心结论
- nbM中的NFT积累可能是年轻发病AD尤其是海马保留型更广泛和严重胆碱能缺陷的基础。
- 评估AD结局时应考虑发病年龄、性别和载脂蛋白E基因型。
研究设计与样本
- 横断面研究,回顾性提取临床记录并定量评估nbM的NFT和神经元计数,于2019年1月在Mayo Clinic完成。
- 使用佛罗里达尸检多种族(FLAME)队列,1991年至2015年连续入组,共评估1361例AD亚型和103例非痴呆对照。
主要发现
- nbM每0.125 mm²的硫黄素S阳性NFT中位数(IQR):海马保留型AD 14(9-20),典型AD 10(5-16),边缘 predominance 型AD 8(5-11)(P < .001)。
- nbM每平方毫米神经元密度中位数(IQR):海马保留型AD 22(17-28),典型AD 25(19-30),边缘 predominance 型AD 26(19-32)(P = .002)。
- 海马保留型AD中nbM较高NFT积累与较年轻发病年龄相关(β = -1.5;95% CI,-2.9至-0.15;P = .03)。
- 典型AD中nbM较高NFT积累与较年轻发病年龄(β = -3.2;95% CI,-3.9至-2.4;P < .001)、女性(β = 2.5;95% CI,1.4-3.5;P < .001)、APOE ε4等位基因(β = 1.3;95% CI,0.15-2.5;P = .03)及较低MMSE评分(β = -1.8;95% CI,-3.2至-0.31;P = .02)相关。
- 边缘 predominance 型AD中人口学及临床进展变量与nbM的NFT积累无关。
临床怎么用
- 对年轻发病AD患者,尤其怀疑海马保留型时,应关注更严重的胆碱能缺陷可能。
- 评估AD预后或治疗反应时,需考虑发病年龄、性别和APOE基因型。
局限性
- 横断面尸检研究,无法确定NFT积累与神经元丢失的因果关系。
- 样本来自特定尸检队列,可能存在选择偏倚。
- 仅评估前部nbM,未涵盖整个胆碱能系统。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Corticolimbic patterns of neurofibrillary tangle (NFT) accumulation define neuropathologic subtypes of Alzheimer disease (AD), which underlie the clinical heterogeneity observed antemortem. The cholinergic system, which is the target of acetylcholinesterase inhibitor therapy, is selectively vulnerable in AD. OBJECTIVE: To investigate the major source of cholinergic innervation, the nucleus basalis of Meynert (nbM), in order to determine whether there is differential involvement of NFT accumulation or neuronal loss among AD subtypes. DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study, retrospective abstraction of clinical records and quantitative assessment of NFTs and neuron counts in the nbM was completed in January 2019 at the Mayo Clinic using the Florida Autopsied Multi-Ethnic (FLAME) cohort, which had been accessioned from 1991 until 2015. The FLAME cohort is derived from the deeded autopsy program funded throughout the State of Florida's memory disorder clinic referral services. Of the 2809 consecutively accessioned FLAME cohort, 1464 were identified as neuropathologically diagnosed AD cases and nondemented normal controls available for clinicopathologic assessment. Quantification of NFTs and neuronal density in the anterior nbM was performed blinded to neuropathologic groupings. MAIN OUTCOMES AND MEASURES: Demographic and clinical characteristics, including cognitive decline measured using the Mini-Mental State Examination score (range, 0-30), were evaluated. The anterior nbM was investigated quantitatively for neuronal loss and NFT accumulation. RESULTS: In total, 1361 AD subtypes and 103 nondemented controls were assessed. The median (interquartile range) age at death was 72 (66-80) years in hippocampal sparing (HpSp) AD, 81 (76-86) years in typical AD, and 86 (82-90) years in limbic predominant AD. The median (interquartile range) count per 0.125 mm2 of thioflavin S-positive NFTs was highest in the nbM of HpSp AD (14 [9-20]; n = 163), lower in typical AD (10 [5-16]; n = 937), and lowest in limbic predominant AD (8 [5-11], n = 163) (P < .001). The median (interquartile range) neuronal density per millimeters squared was lowest in HpSp AD cases (22 [17-28]; n = 148), higher in typical AD (25 [19-30]; n = 727), and highest in limbic predominant AD (26 [19-32]; n = 127) (P = .002). Multivariable regression modeling of clinical and demographic variables was performed to assess overlap in NFT accumulation and neuronal density differences among AD subtypes. Higher NFT accumulation in the nbM was associated with younger age at onset for HpSp AD (β, -1.5; 95% CI, -2.9 to -0.15; P = .03) and typical AD (β, -3.2; 95% CI, -3.9 to -2.4; P < .001). In addition, higher NFT accumulation in the nbM of typical AD cases was associated with female sex (β, 2.5; 95% CI, 1.4-3.5; P < .001), apolipoprotein E ε4 allele (β, 1.3; 95% CI, 0.15-2.5; P = .03), and lower Mini-Mental State Examination scores (β, -1.8; 95% CI, -3.2 to -0.31; P = .02). Demographic and clinical progression variables were not associated with NFT accumulation in the nbM of limbic predominant AD cases. CONCLUSIONS AND RELEVANCE: These data provide supportive evidence that NFT accumulation in the nbM may underlie more widespread and severe cholinergic deficits in young-onset AD, in particular in patients with HpSp AD. Moreover, these findings underscore the importance of considering age at onset, sex, and apolipoprotein E genotype when assessing outcomes in AD.
引用
- Hanna Al-Shaikh FS, Duara R, Crook JE, et al. Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease. JAMA Neurol. 2020. PMID: 31657834. doi:10.1001/jamaneurol.2019.3606
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。